Video Review: Talking Biopolitics – A conversation with Paul Knoepfler and Nathaniel Comfort
By Dr. Rebecca Dimond,
BioNews
| 02. 01. 2016
Untitled Document
On 26 January 2016, the Center for Genetics and Society hosted an online discussion on 'Exploring heritable genetic modification: the promise and perils of altering future humans'. Paul Knoepfler, author of the 2015 book 'GMO Sapiens: The Life-Changing Science of Designer Babies', was interviewed by science historian Nathaniel Comfort.
I was looking forward to this webinar. The discussion was timely, following the passing of legislation on mitochondrial donation in the UK in 2015, and amid current debates about gene-editing technologies, such as CRISPR. Introducing the conversation, Marcy Darnovsky told the audience that genetic modification is 'now with us', a thought she described as both lively and sobering. Knoepfler's views about these developments are well known – during the UK mitochondrial donation debates, he contributed evidence to the scientific reviews, was mentioned at the House of Commons and House of Lords and hosts his own popular blog. He recently tweeted that he was 'excited about genetic modification' but was also cautious about 'talk of clinic use'.
Much of the conversation focused on the risks and benefits of...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
By Gemma Conroy, Nature | 06.27.2024
Image by Robina Weermeijer from Unsplash
A molecular-editing tool that’s small enough to be delivered to the brain shuts down the production of proteins that cause prion diseases, a rare but deadly group of neurodegenerative disorders.
The system — known...
By Mesha Maren , Salon | 07.20.2024
By Alcott Wei, South China Morning Post | 07.13.2024
China has banned all clinical research involving germline genome editing under a newly released ethics guideline.
Germline gene engineering relates to altering the DNA in sperm, eggs or early embryos to introduce changes that can be inherited.
“Any clinical research...